Overview

Etanercept (Enbrel®) in Psoriasis - Pediatrics

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of etanercept (Enbrel®) in children with Psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Etanercept